All Updates

All Updates

icon
Filter
M&A
Augmedics acquires assets of bankrupt Surgalign for USD 0.9 million
Extended Reality
Aug 1, 2023
This week:
Management news
6K Additive awarded project to develop C-103 powder for additive manufacturing
Additive Manufacturing
Sep 27, 2024
Partnerships
WAAM3D partners with Innovative Space Carrier, Cranfield University, and Aichi Sangyo for space transport development
Additive Manufacturing
Sep 19, 2024
Product updates
Microsoft launches Face Check with Microsoft Entra Verified ID
Facial Recognition
Sep 11, 2024
Funding
3DEO raises USD 3.5 million in strategic investment from Mizuho Bank
Additive Manufacturing
Sep 6, 2024
Product updates
HyperWrite launches open-source AI model Reflection 70 billion
Generative AI Applications
Sep 5, 2024
Product updates
Google begins US rollout of AI-powered Ask Photos feature
Generative AI Applications
Sep 5, 2024
Funding
Management news
HDAX Therapeutics raises USD 3.2 million in seed funding to progress pipeline and advance preclinical candidates into trials
Precision Medicine
Sep 5, 2024
Partnerships
Sequentify partners with Dexter to expand genomic diagnostics in Romania
Precision Medicine
Sep 5, 2024
Partnerships
Elevate partners with Cultivatd for European expansion
Vertical Farming
Sep 5, 2024
Product updates
Moolec confirms harvest of its genetically engineered plant-grown products
Crop Biotech
Sep 5, 2024
Extended Reality

Extended Reality

Aug 1, 2023

Augmedics acquires assets of bankrupt Surgalign for USD 0.9 million

M&A

  • Augmedics, an AR surgical navigation platform, has acquired the digital health assets of Surgalign and Holo Surgical for USD 0.9 million in cash.

  • Surgalign's digital health offerings include the HOLO Portal, an AI-driven AR guidance system that provides intraoperative image-guided navigation of a patient's spine. The patented AR system enables a 3D overlay of the patient's anatomy and real-time superimposition of 3D targeting and trajectory on surgical instruments.

  • Augmedics plans to integrate these offerings with its own AR-based and AI-based solutions, including its FDA-cleared xvision platform.

  • Analyst QuickTake: The acquisition allows Augmedics to bolster its product offering, which announced the launch of a new set of FDA-cleared features to expand capabilities of its xvision platform in March 2023 . Augmedics also raised USD 82.5 million in a Series D funding round in June 2023 , with funding being utilized to expand Augmedics' US commercial footprint and enable mass-scale adoption of its proprietary xvision technology. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.